一周行情 上周（1月26日至1月30日）医药生物指数下跌2.71%，跑输上证指数1.75个百分点。创新药（BK1106）周内下跌4.06%；恒生医疗保健业指数（HSCICH）周内下跌2.72%；港股创新药ETF（513120）周内下跌3.71%。 一周点评 医药生物板块集体走弱，创新药相关指数领跌，核心症结在于利好效应失效，政策与产业利好已难以对冲市场现实顾虑。尽管创新药领域持续有政策支持、...
Source Link一周行情 上周（1月26日至1月30日）医药生物指数下跌2.71%，跑输上证指数1.75个百分点。创新药（BK1106）周内下跌4.06%；恒生医疗保健业指数（HSCICH）周内下跌2.72%；港股创新药ETF（513120）周内下跌3.71%。 一周点评 医药生物板块集体走弱，创新药相关指数领跌，核心症结在于利好效应失效，政策与产业利好已难以对冲市场现实顾虑。尽管创新药领域持续有政策支持、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.